The information contained in these releases was current on the date the releases were issued and will become outdated over time. Lilly does not assume any responsibility for updating information in these releases.
Releases
 |
Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp.
Jan 24, 2012
|
11.6 KB |
|
| |
GREENFIELD, Ind., Jan. 24, 2012 /PRNewswire/ -- Elanco, the animal health division of Eli Lilly and Company (NYSE: LLY), today announced that Lilly has signed an agreement to acquire ChemGen Corp., a privately held bioscience company specializing in the development and commercialization of innovative feed enzyme products that improve the efficiency...
|
|
/C O R R E C T I O N -- Eli Lilly and Company/
Jan 5, 2012
|
14.9 KB |
|
| |
In the news release, Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance, issued Jan. 5, 2012 by Eli Lilly and Company over PR Newswire, we are advised by the company that the second paragraph, second sentence, should read "and $.18 of asset impairment " rather than "and $.13 of asset impairment" as originally issued ina...
|
|
Lilly Comments on 2011 Financial Guidance and Announces 2012 Financial Guidance
Jan 5, 2012
|
14.0 KB |
|
| |
INDIANAPOLIS, Jan. 5, 2012 /PRNewswire/ --
Company expects to meet or exceed 2011 EPS guidance.
2012 financial guidance reflects revenue and earnings declines due to Zyprexa patent expiration.
2012 revenue anticipated to be between $21.8 billion and $22.8 billion.
Company expects to keep 2012 operating expenses essentially f...
|
|
Lilly Sets Dates and Conference Calls for 2012 Financial Guidance and Fourth-Quarter 2011 Financial Results Announcements
Dec 16, 2011
|
7.1 KB |
|
| |
INDIANAPOLIS, Dec. 16, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2012 on Thursday, January 5, 2012 and, separately, will announce its financial results for the fourth quarter and full year of 2011 on Tuesday, January 31, 2012. On each day, Lilly will also conduct conference calls with the inves...
|
|
Lilly Recognized as One of the Best Places to Work for LGBT Equality
Dec 14, 2011
|
7.8 KB |
|
| |
INDIANAPOLIS, Dec. 14, 2011 /PRNewswire/ -- For the sixth consecutive year, Eli Lilly and Company (NYSE: LLY) has received a 100 percent rating on the Human Rights Campaign (HRC) Corporate Equality Index (CEI) for lesbian, gay, bisexual and transgender (LGBT) equality in the workplace.
(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLO...
|
|
Lilly Declares First-Quarter 2012 Dividend
Dec 12, 2011
|
6.4 KB |
|
| |
INDIANAPOLIS, Dec. 12, 2011 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) today declared a dividend for the first quarter of 2012 of $0.49 a share on outstanding common stock.
The dividend is payable March 9, 2012 to shareholders of record at the close of business on February 15, 2012.
Lilly, a leading ...
|
|
Katherine Baicker Elected to Lilly Board of Directors
Dec 12, 2011
|
8.2 KB |
|
| |
INDIANAPOLIS, Dec. 12, 2011 /PRNewswire/ -- Board of Directors of Eli Lilly and Company (NYSE: LLY) has elected Katherine Baicker, Ph.D. as a new member, effective December 12, 2011. Baicker, 40, is Professor of Health Economics in the Department of Health Policy and Management at the Harvard School of Public Health. She is also a research associat...
|
|
Lilly Oncology Reveals Findings From Study of JAK2 Inhibitor for Blood Cancers at ASH Meeting
Dec 12, 2011
|
15.8 KB |
|
| |
SAN DIEGO, Dec. 12, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced data from an oncology pipeline molecule today at the 53rd Annual Meeting of the American Society of Hematology (ASH). At the meeting, Lilly Oncology presented Phase I data from the investigational therapy LY2784544, a small-molecule Janus kinase 2 (JAK2) inhibitor,...
|
|
Lilly for Better Health™ Expands Website to Include Spanish Health Information and Interactive Tools
Dec 9, 2011
|
10.9 KB |
|
| |
INDIANAPOLIS, Dec. 9, 2011 /PRNewswire/ -- Lilly for Better Health™, a program of Lilly USA, LLC, (NYSE: LLY) that helps individuals live healthier, more active lives, has launched an expanded Spanish portal on www.lillyforbetterhealth.com.
The newly enhanced En Espanol section features a 60-page interactive health album that provide...
|
|
Taking Sex Off Their To-Do List: Most Couples Prefer Spontaneity in the Bedroom
Dec 8, 2011
|
12.5 KB |
|
| |
INDIANAPOLIS, Dec. 8, 2011 /PRNewswire/ -- Sex is spontaneous, or unplanned, for the majority of men and women in the U.S. and around the world, a recent survey found. In the U.S., 76 percent of all respondents said they do not plan ahead for sex, compared to the global average of 86 percent.
According to the poll, in the U.S., 71 percent o...
|
|
Eli Lilly and Company Named a Top Global Company for Leaders
Dec 1, 2011
|
7.8 KB |
|
| |
INDIANAPOLIS, Dec. 1, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has been named one of the top 25 global companies for leaders by Aon Hewitt in partnership with FORTUNE and the RBL Group. Lilly ranked 16th on the Global 25 list and 12th on the North American list.
The survey is one of the most comprehensive studies of talent mana...
|
|
Lilly Announces First and Only International, Prospective Observational Study Designed to Understand Barriers to Progression of Insulin Treatment
Dec 1, 2011
|
54.7 KB |
|
| |
INDIANAPOLIS, Dec. 1, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles that people with type 2 diabetes face that prevent them from reaching their ultimate treatment goals.
(Logo: http://phot...
|
|
Lilly Provides Additional Funding to Infectious Disease Research Institute to Identify New Tuberculosis Therapies
Nov 17, 2011
|
11.2 KB |
|
| |
SEATTLE, Nov. 17, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that it is providing more than $4 million in additional funding to the Infectious Disease Research Institute. The funding will allow IDRI to continue its early phase drug discovery efforts focused on identifying new and better therapies in the fight against tub...
|
|
New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
Nov 16, 2011
|
19.5 KB |
|
| |
ORLANDO, Fla., Nov. 16, 2011 /PRNewswire/ -- An analysis of the TRITON-TIMI 38 trial presented today in an oral session at the American Heart Association (AHA) Scientific Sessions meeting examined the effect of Effient® (prasugrel) on cardiovascular (CV) events (CV death, myocardial infarction [MI] and stroke) compared to clopidogrel relative ...
|
|
F.A.C.E. Diabetes and Anthony Anderson Ask Americans to Rethink Generation D
Nov 11, 2011
|
58.0 KB |
|
| |
INDIANAPOLIS, Nov. 11, 2011 /PRNewswire/ -- For the second year in a row, award-winning actor and comedian Anthony Anderson is teaming up with Eli Lilly and Company's Fearless African-Americans Connected and Empowered (F.A.C.E.) Diabetes initiative to remove the stereotype of Generation D—the belief that type 2 diabetes is an older person's d...
|
|
Lilly CEO Lechleiter Outlines Opportunities for Improved Health and Economic Growth in Asia-Pacific Region
Nov 10, 2011
|
11.5 KB |
|
| |
HONOLULU, Nov. 10, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) Chairman, President and Chief Executive Officer John C. Lechleiter, Ph.D., today said new trade agreements, effective public policies, and continued collaboration to bring innovation to patients are needed to assure improved health and economic prosperity in the Asia-Pacific ...
|
|
Lilly to Recognize Employees Who Have Served Our Country Through the Military
Nov 9, 2011
|
10.6 KB |
|
| |
INDIANAPOLIS, Nov. 9, 2011 /PRNewswire/ -- U.S. military veterans employed by Eli Lilly and Company (NYSE: LLY) will be recognized for their service to the country during a special Veterans Recognition Event at the Lilly Corporate Center 4 p.m. Monday, Nov. 14. The event is sponsored by the Veterans Leadership Network (VLN), an employee resource gr...
|
|
Lilly Surpasses United Way 2011 Campaign Goal
Nov 8, 2011
|
7.5 KB |
|
| |
INDIANAPOLIS, Nov. 8, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) Chairman, President and Chief Executive Officer John Lechleiter Ph.D. today will present a $12.3 million check to the United Way. The check represents the contributions of Lilly's U.S. employees and retirees and a matching gift amount from the Lilly Foundation. The funds ...
|
|
Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin
Nov 8, 2011
|
17.1 KB |
|
| |
SAN DIEGO and INDIANAPOLIS, Nov. 8, 2011 /PRNewswire/ -- Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) ("Amylin") and Eli Lilly and Company (NYSE: LLY) ("Lilly") today announced an agreement to terminate their alliance for exenatide and resolve the outstanding litigation between the companies. As part of the agreement, the parties will transition ful...
|
|
FDA Approves ERBITUX® (cetuximab) for First-Line Recurrent Locoregional or Metastatic Head and Neck Cancer in Combination with Platinum-based Chemotherapy with 5-Fluorouracil
Nov 7, 2011
|
80.7 KB |
|
| |
(New York and Indianapolis, November 7, 2011) -Eli Lilly and Company (NYSE: LLY) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved ERBITUX® (cetuximab), in comb...
|
|
|
